PREEMPT CRC: PREvention Employing a Multiomics Plasma-based Test for ColoRectal Cancer

Date Added
June 22nd, 2020
PRO Number
Don Rockey

List of Studies

Aging, Cancer/Other, Colonoscopy, Digestive System, Disease Prevention, Men's Health, Prostate

The Sponsor of this research study is trying to develop a new experimental diagnostic blood test that may help detect colorectal cancer and other diseases. A diagnostic test identifies a specific disease or condition. Experimental means the test has not received approval by the United States Food and Drug Administration (FDA) for sale.
The main goal of this research study is to collect health information and blood samples from people who are going to have a standard-of-care screening colonoscopy. The blood samples along with other health information from patients who take part in the study may help the Sponsor develop new diagnostic tests that may help detect cancer or other diseases in other patients in the future.

Recruitment Contact
Megan Bickford

-- OR --